These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

225 related articles for article (PubMed ID: 34557007)

  • 1. Combination of Metformin and Exercise in Management of Metabolic Abnormalities Observed in Type 2 Diabetes Mellitus.
    Jevtovic F
    Diabetes Metab Syndr Obes; 2021; 14():4043-4057. PubMed ID: 34557007
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Metabolism and insulin signaling in common metabolic disorders and inherited insulin resistance.
    Højlund K
    Dan Med J; 2014 Jul; 61(7):B4890. PubMed ID: 25123125
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Therapeutic Applications of Type 2 Diabetes Mellitus Drug Metformin in Patients with Osteoarthritis.
    Song P; Hwang JS; Park HC; Kim KK; Son HJ; Kim YJ; Lee KM
    Pharmaceuticals (Basel); 2021 Feb; 14(2):. PubMed ID: 33668426
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A refined-JinQi-JiangTang tablet ameliorates prediabetes by reducing insulin resistance and improving beta cell function in mice.
    Gao LH; Liu Q; Liu SN; Chen ZY; Li CN; Lei L; Sun SJ; Li LY; Liu JL; Shen ZF
    J Ethnopharmacol; 2014; 151(1):675-85. PubMed ID: 24286962
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Activation of the AMPK/Sirt1 pathway by a leucine-metformin combination increases insulin sensitivity in skeletal muscle, and stimulates glucose and lipid metabolism and increases life span in Caenorhabditis elegans.
    Banerjee J; Bruckbauer A; Zemel MB
    Metabolism; 2016 Nov; 65(11):1679-1691. PubMed ID: 27456392
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Metformin and AMPK: an old drug and a new enzyme in the context of metabolic syndrome].
    Santomauro Júnior AC; Ugolini MR; Santomauro AT; Souto RP
    Arq Bras Endocrinol Metabol; 2008 Feb; 52(1):120-5. PubMed ID: 18345405
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cellular Energy Sensing and Metabolism-Implications for Treating Diabetes: The 2017 Outstanding Scientific Achievement Award Lecture.
    Steinberg GR
    Diabetes; 2018 Feb; 67(2):169-179. PubMed ID: 29358486
    [No Abstract]   [Full Text] [Related]  

  • 8. The role of AMP kinase in diabetes.
    Misra P; Chakrabarti R
    Indian J Med Res; 2007 Mar; 125(3):389-98. PubMed ID: 17496363
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The antihyperglycaemic effect of metformin: therapeutic and cellular mechanisms.
    Wiernsperger NF; Bailey CJ
    Drugs; 1999; 58 Suppl 1():31-9; discussion 75-82. PubMed ID: 10576523
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Regulation of energy metabolism by AMPK: a novel therapeutic approach for the treatment of metabolic and cardiovascular diseases].
    Foretz M; Taleux N; Guigas B; Horman S; Beauloye C; Andreelli F; Bertrand L; Viollet B
    Med Sci (Paris); 2006 Apr; 22(4):381-8. PubMed ID: 16597407
    [TBL] [Abstract][Full Text] [Related]  

  • 11. AMP activated protein kinase: a next generation target for total metabolic control.
    Misra P
    Expert Opin Ther Targets; 2008 Jan; 12(1):91-100. PubMed ID: 18076373
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Regulation of glucose transport by the AMP-activated protein kinase.
    Fujii N; Aschenbach WG; Musi N; Hirshman MF; Goodyear LJ
    Proc Nutr Soc; 2004 May; 63(2):205-10. PubMed ID: 15294031
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Berberine inhibits hepatic gluconeogenesis via the LKB1-AMPK-TORC2 signaling pathway in streptozotocin-induced diabetic rats.
    Jiang SJ; Dong H; Li JB; Xu LJ; Zou X; Wang KF; Lu FE; Yi P
    World J Gastroenterol; 2015 Jul; 21(25):7777-85. PubMed ID: 26167077
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Understanding the glucoregulatory mechanisms of metformin in type 2 diabetes mellitus.
    Foretz M; Guigas B; Viollet B
    Nat Rev Endocrinol; 2019 Oct; 15(10):569-589. PubMed ID: 31439934
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Evidence for organic cation transporter-mediated metformin transport and 5'-adenosine monophosphate-activated protein kinase activation in rat skeletal muscles.
    Oshima R; Yamada M; Kurogi E; Ogino Y; Serizawa Y; Tsuda S; Ma X; Egawa T; Hayashi T
    Metabolism; 2015 Feb; 64(2):296-304. PubMed ID: 25433920
    [TBL] [Abstract][Full Text] [Related]  

  • 16. AMP-activated protein kinase and muscle glucose uptake.
    Musi N; Goodyear LJ
    Acta Physiol Scand; 2003 Aug; 178(4):337-45. PubMed ID: 12864738
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Role of AMP-activated protein kinase in mechanism of metformin action.
    Zhou G; Myers R; Li Y; Chen Y; Shen X; Fenyk-Melody J; Wu M; Ventre J; Doebber T; Fujii N; Musi N; Hirshman MF; Goodyear LJ; Moller DE
    J Clin Invest; 2001 Oct; 108(8):1167-74. PubMed ID: 11602624
    [TBL] [Abstract][Full Text] [Related]  

  • 18. PAN-AMPK activator O304 improves glucose homeostasis and microvascular perfusion in mice and type 2 diabetes patients.
    Steneberg P; Lindahl E; Dahl U; Lidh E; Straseviciene J; Backlund F; Kjellkvist E; Berggren E; Lundberg I; Bergqvist I; Ericsson M; Eriksson B; Linde K; Westman J; Edlund T; Edlund H
    JCI Insight; 2018 Jun; 3(12):. PubMed ID: 29925691
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Impact of Disturbed Glucose Homeostasis Regulated by AMPK in Endometrium on Embryo Implantation in Diabetes Mice.
    Zhang XQ; Zhao D; Ma YD; Wang YC; Zhang LX; Guo WJ; Zhang JH; Nie L; Yue LM
    Reprod Sci; 2020 Sep; 27(9):1752-1757. PubMed ID: 32086756
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effect of Shenzhu Tiaopi granule on hepatic insulin resistance in diabetic Goto-Kakizakirats via liver kinase B1/adenosine 5'-monophosphate/mammalian target of rapamycin signaling pathway.
    Yin Y; Fang Z; Wu Y; You L
    J Tradit Chin Med; 2021 Feb; 41(1):107-116. PubMed ID: 33522203
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.